Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 14, Pages -Publisher
MDPI
DOI: 10.3390/ijms23148018
Keywords
breakthrough cancer pain (BTcP); optopharmacology; metabotropic glutamate receptor 5; analgesia; thalamus
Funding
- Italian Ministry of Health [GR-2016-02362046]
Ask authors/readers for more resources
Breakthrough cancer pain (BTcP) is a sudden and transient exacerbation of pain in patients treated with opioid analgesics. Light-activated drugs offer a novel strategy for rapid pain control without systemic side effects. Activation of mGlu5 receptors in the thalamus with light-induced compounds showed analgesic effects in inflammatory and neuropathic pain models. This study demonstrates the potential use of optopharmacology in BTcP treatment.
Breakthrough cancer pain (BTcP) refers to a sudden and transient exacerbation of pain, which develops in patients treated with opioid analgesics. Fast-onset analgesia is required for the treatment of BTcP. Light-activated drugs offer a novel potential strategy for the rapid control of pain without the typical adverse effects of systemic analgesic drugs. mGlu5 metabotropic glutamate receptor antagonists display potent analgesic activity, and light-induced activation of one of these compounds (JF-NP-26) in the thalamus was found to induce analgesia in models of inflammatory and neuropathic pain. We used an established mouse model of BTcP based on the injection of cancer cells into the femur, followed, 16 days later, by systemic administration of morphine. BTcP was induced by injection of endothelin-1 (ET-1) into the tumor, 20 min after morphine administration. Mice were implanted with optic fibers delivering light in the visible spectrum (405 nm) in the thalamus or prelimbic cortex to locally activate systemically injected JF-NP-26. Light delivery in the thalamus caused rapid and substantial analgesia, and this effect was specific because light delivery in the prelimbic cortex did not relieve BTcP. This finding lays the groundwork for the use of optopharmacology in the treatment of BTcP.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available